A detailed history of Dimensional Fund Advisors LP transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 199,558 shares of GRTS stock, worth $5,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares
199,558
Previous 199,558 -0.0%
Holding current value
$5,986
Previous $123,000 6.5%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$0.62 - $2.35 $53,966 - $204,548
-87,042 Reduced 30.37%
199,558 $123,000
Q1 2024

May 10, 2024

BUY
$1.96 - $2.9 $281,985 - $417,223
143,870 Added 100.8%
286,600 $736,000
Q4 2023

Feb 07, 2024

SELL
$1.28 - $2.85 $13,273 - $29,554
-10,370 Reduced 6.77%
142,730 $291,000
Q3 2023

Nov 09, 2023

SELL
$1.19 - $2.26 $61,127 - $116,091
-51,368 Reduced 25.12%
153,100 $263,000
Q2 2023

Aug 09, 2023

SELL
$1.66 - $3.03 $198,982 - $363,203
-119,869 Reduced 36.96%
204,468 $398,000
Q1 2023

May 12, 2023

SELL
$2.13 - $3.74 $18,296 - $32,126
-8,590 Reduced 2.58%
324,337 $901,000
Q4 2022

Feb 09, 2023

BUY
$2.17 - $3.92 $139,995 - $252,894
64,514 Added 24.04%
332,927 $1.15 Million
Q3 2022

Nov 10, 2022

BUY
$2.46 - $4.75 $267,187 - $515,911
108,613 Added 67.97%
268,413 $690,000
Q2 2022

Aug 12, 2022

SELL
$1.77 - $4.34 $35,403 - $86,808
-20,002 Reduced 11.12%
159,800 $387,000
Q1 2022

May 13, 2022

SELL
$4.03 - $12.19 $182,160 - $551,000
-45,201 Reduced 20.09%
179,802 $741,000
Q4 2021

Feb 09, 2022

BUY
$8.76 - $13.71 $409,854 - $641,449
46,787 Added 26.25%
225,003 $2.89 Million
Q3 2021

Nov 12, 2021

SELL
$6.41 - $13.54 $259,553 - $548,261
-40,492 Reduced 18.51%
178,216 $1.93 Million
Q2 2021

Aug 12, 2021

BUY
$8.13 - $10.2 $1.32 Million - $1.66 Million
162,836 Added 291.44%
218,708 $2 Million
Q1 2021

May 14, 2021

SELL
$4.07 - $27.11 $32,653 - $217,503
-8,023 Reduced 12.56%
55,872 $526,000
Q4 2020

Feb 25, 2021

BUY
$2.57 - $4.22 $164,210 - $269,636
63,895 New
63,895 $252,000

Others Institutions Holding GRTS

About Gritstone bio, Inc.


  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.